Based in France, DIAFIR was founded in 2011 and has recently received an €800.00K venture round investment on 19 May 2021 from Go Capital and Happy Capital. This biotechnology and manufacturing startup specializes in developing, manufacturing, and marketing in situ and fast biological analytical tools based upon unique infrared fiber sensor technology. With applications in POC medical diagnostics, food analysis, and organic chemical reaction monitoring, DIAFIR systems boast the capability to detect chronic liver disease, infections, or tumors within a 5-minute process. The company operates within the industries of Biotechnology, Manufacturing, Medical Devices, as well as Autonomous and Sensor Tech.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | €800.00K | 2 |
|
19 May 2021 |
| Venture Round | €270.00K | 1 |
|
14 Jan 2015 |
| Seed Round | €300.00K | 1 |
|
14 Jun 2012 |
No recent news or press coverage available for DIAFIR.
We care about your data, and we'd love to use cookies make your experience better.
